AREDS 2 is a high-dose vitamin formula that slows vision loss from intermediate age-related macular degeneration, but it does not prevent or cure AMD.
Age-related macular degeneration is a leading cause of vision loss in older Americans, and the AREDS 2 formula is the one supplement combination a large clinical trial has shown to change its course. What AREDS 2 is good for hinges on one variable: how far the disease has already progressed. Guess wrong and the bottle is an expensive no-op.
The National Eye Institute ran both trials, and its written guidance is candid about the limits. This is not a multivitamin, not a prevention pill, and not a replacement for an eye exam.
Which Stages Of AMD Does AREDS 2 Help?
AREDS 2 slows progression for people with intermediate AMD in one or both eyes, and it may protect the second eye in someone who already has late AMD in one eye. It does nothing for early AMD, for no AMD at all, or for late AMD in both eyes.
The AREDS and AREDS2 trials measured roughly a 25% reduction in the risk of moving from intermediate to advanced AMD among participants who fit the study criteria. That number is real but modest, and it describes slowed damage — not restored vision.
Stage decides everything because advanced AMD is where the irreversible loss happens. Someone with intermediate AMD still has usable central vision, and the point of the supplement is to keep it usable longer. Once both eyes reach late-stage disease, the National Eye Institute says AREDS 2 probably will not help.
AREDS 2 Supplements For Eye Health: What’s In The Formula
The studied AREDS 2 formula pairs high-dose vitamin C and vitamin E with zinc, copper, lutein, and zeaxanthin — and it contains no beta-carotene.
Those amounts sit far above any standard multivitamin, which is why the National Eye Institute says ordinary vitamins do not substitute for the studied blend.
| Ingredient | Daily Amount In AREDS 2 | Why It’s There |
|---|---|---|
| Vitamin C | 500 mg | Antioxidant in the studied blend |
| Vitamin E | 400 IU | Antioxidant; interacts with some drugs |
| Zinc | 80 mg | Mineral tied to slower progression |
| Copper | 2 mg | Offsets zinc’s effect on copper absorption |
| Lutein | 10 mg | Macular pigment; replaced beta-carotene |
| Zeaxanthin | 2 mg | Pairs with lutein in the retina |
| Beta-carotene | None | Dropped over smoker lung-cancer risk |
Beta-carotene is the ingredient that changed between the two trials. Original AREDS used 15 mg of it; AREDS2 dropped it because beta-carotene was tied to a higher lung-cancer risk in people who smoked or once smoked. Smokers and former smokers should pick the beta-carotene-free formula without hesitating.
Fish oil does not belong on the list. Testing omega-3 fatty acids alongside the AREDS formula turned up no extra AMD benefit, so a separate fish-oil capsule adds cost without adding protection. The National Eye Institute’s guidance on nutritional supplements for age-related macular degeneration covers the current formulation and its caveats in one place.
Dose, Interactions, And The Mistakes That Waste Money
Get your AMD stage confirmed by an eye doctor first, then buy a product labeled AREDS 2 and check its Supplement Facts panel against the studied amounts.
- Have an ophthalmologist or optometrist stage the disease — intermediate in one or both eyes is the cutoff that matters.
- Choose AREDS 2 on the label. The original AREDS product is the beta-carotene version.
- Compare the back panel to the table above. Serving sizes differ by brand, and one capsule rarely equals a full daily dose.
- List every prescription, over-the-counter drug, and supplement for your clinician before you start.
- Take it daily at the labeled serving. The trial evidence comes from consistent daily use, not occasional doses.
You’ll know it worked when the front label reads AREDS 2 and the numbers on the back match the table.
High doses carry their own risks. Vitamin E can interact with blood thinners, chemotherapeutic agents, and lipid-lowering drugs, and stacking a second eye formula or a multivitamin on top can push your zinc and vitamin E intake higher than you intended. AREDS 2 also does not replace routine eye exams, treatment for wet AMD, or urgent evaluation of new distortion, flashes, or floaters.
Labels are where buying decisions go wrong, which is why our tested AREDS 2 supplement roundup narrows the field to formulas that match the studied doses.
The rule that settles it: AREDS 2 earns its place for intermediate AMD in one or both eyes, and possibly for protecting the second eye when one already has late AMD. Taken daily at the labeled dose with a doctor in the loop, it buys time. Every other scenario is money spent on hope.
Common Questions
Can These Supplements Reverse Vision Already Lost?
No. The AREDS and AREDS2 trials measured a lower risk of progression, not recovery of damaged retinal cells. Central vision lost to advanced AMD does not come back with a vitamin. Anyone promising restored sight from a supplement is selling something the clinical evidence does not support, and that includes every formula built on the studied blend.
Do They Do Anything For Cataracts?
Nothing demonstrated. AREDS and AREDS2 found no effect of the supplement blend on cataract formation or progression, so it is not a cataract preventive. Cataract surgery remains the treatment, and eye-care professionals do not prescribe AREDS 2 for lens clouding. Taking it hoping for clearer lenses is a common and costly misunderstanding.
Is It Fine To Take AREDS 2 Alongside A Daily Multivitamin?
Only after checking your total intake with a clinician. Both products can contain zinc, vitamin E, and copper, and the AREDS 2 doses are already high. Doubling up can push you past safe limits without any extra eye benefit. Bring every bottle to the appointment so the combined totals get reviewed together.
Sources
- National Eye Institute. “Nutritional Supplements for Age-Related Macular Degeneration” Supports the AREDS 2 formula, the stage-based indications, and the smoker warning.
- National Eye Institute. “AREDS/AREDS2 Frequently Asked Questions” Supports the roughly 25% progression reduction, the omega-3 finding, and the cataract results.
- National Eye Institute. “About AREDS and AREDS2” Supports the trial design and the exact studied ingredient amounts.